RecruitingNot ApplicableNCT05556759

Anterior Iliopsoas Muscle Space Block Versus Supra-iliac Anterior Quadratus Lumborum Block in Total Hip Arthroplasty

Anterior Iliopsoas Muscle Space Block Versus Supra-Iliac Anterior Quadratus Lumborum Block for Analgesia in Total Hip Arthroplasty: A Randomized Controlled Trial


Sponsor

Zagazig University

Enrollment

72 participants

Start Date

Sep 30, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Approximately 1.66 million hip fractures happen in a year worldwide. About 95% of these fractures happen in individuals older than 60 years. Surgical treatment involving THA is considered the best option for patients with hip fractures and those with degenerative changes in the hip joint, especially in the elderly, however, it is associated with moderate to severe postoperative pain. Pain is one of the main factors limiting ambulation, increasing the risk of thromboembolism by immobility, and causing metabolic changes that affect other systems. Therefore, individualized pain management with the use of appropriate analgesia techniques is of paramount importance. Moreover, early intervention of rehabilitation aiming at a better postoperative recovery may reduce the length of hospital stay and return to daily. Effective pain management is one of the crucial components of enhanced recovery after surgery (ERAS). Numerous regional anesthetic techniques have been used to provide analgesia following THA, including intrathecal morphine, epidural analgesia, fascia iliaca block, lumber plexus block, sacral plexus block, and local infiltration analgesia, however, each of these techniques has specific limitations that prevent them from being the analgesic technique of choice for THA. Up to investigators' knowledge, there is no study done to compare the supra-iliac approach to the anterior QL block versus the Anterior iliopsoas muscle space block as pre-emptive analgesia in patients undergoing THA under general anesthesia


Eligibility

Min Age: 50 YearsMax Age: 80 Years

Inclusion Criteria5

  • Patient acceptance.
  • Age 50-80 years old.
  • BMI ≤ 30 kg/m2
  • ASA I - III.
  • Elective total hip arthroplasty under general anesthesia.

Exclusion Criteria6

  • History of allergy to the LA agents used in this study
  • Skin lesion at the needle insertion site,
  • Those with bleeding disorders, sepsis, liver disease, and psychiatric disorders
  • Pre-existing neurological deficit in the lower extremity
  • History of chronic pain and taking analgesics
  • History of cognitive dysfunction or mental illness

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREcontrol

patient will be operated under general anesthesia

PROCEDUREIPS

patients will receive ultrasound-guided anterior IPS block with 30 ml of bupivacaine 0.25% followed by general anesthesia.

PROCEDURESupra-iliac QL

patients will receive ultrasound-guided supra-iliac anterior QL block with 30 ml of bupivacaine 0.25% followed by general anesthesia.


Locations(1)

Faculty of medicine, zagazig university

Zagazig, Alsharqia, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05556759


Related Trials